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NG2-expressing glia (NG2 glia) are a uniformly
distributed and mitotically active pool of cells in the
central nervous system (CNS). In addition to serving
as progenitors of myelinating oligodendrocytes,
NG2 glia might also fulfill physiological roles in CNS
homeostasis, although the mechanistic nature of
such roles remains unclear. Here, we report that abla-
tion of NG2 glia in the prefrontal cortex (PFC) of the
adult brain causesdeficits in excitatory glutamatergic
neurotransmission and astrocytic extracellular gluta-
mate uptake and induces depressive-like behaviors
in mice. We show in parallel that chronic social stress
causes NG2 glia density to decrease in areas critical
to Major Depressive Disorder (MDD) pathophysi-
ology at the time of symptom emergence in stress-
susceptible mice. Finally, we demonstrate that loss
of NG2 glial secretion of fibroblast growth factor 2
(FGF2) suffices to induce the same behavioral defi-
cits. Our findings outline a pathway and role for NG2
glia in CNS homeostasis and mood disorders.
INTRODUCTION
NG2 glia are precursors for myelinating oligodendrocytes (OLs)
and constitute a lineage distinct from astrocytes and microglia
(Nishiyama et al., 1999). In addition, however, many lines of evi-
dence now suggest that NG2 glia might play regulatory roles in
maintaining CNS health in the adult brain, including that they are
ubiquitously distributed throughout the CNS, even in regions of
sparsemyelination (Dawsonet al., 2003), and that this distribution
is tightly self-regulated (Birey and Aguirre, 2015; Hughes et al.,
2013). NG2 glia also represent the most actively cycling cell pop-ulation in the adult CNS (Nishiyama et al., 2009) and swiftly
respond to insults, such as loss of spinal cord motor neurons in
an amyotrophic lateral sclerosis (ALS) mouse model and stab-
wound injuries by increasing proliferation rates and migrating to
the site of insult (Hampton et al., 2004; Kang et al., 2010). More-
over, NG2 glia respond to the alterations in neurotransmission
that follow deprivation of sensory experience in the developing
brain (Hill et al., 2014;Manginet al., 2012). Together, thesestudies
point to potential roles for NG2 glia in adult brain physiology and
possibly in non-myelin-related pathologies. The precise nature
of such functionality has remained elusive.
The incomplete understanding of MDD pathophysiology and
associated failures in developing effective therapeutics are
largely attributed to the lack of robustly-defined underlying
mechanisms (Sullivan et al., 2000; Tennant, 2002), which are
likely to involve an interplay of multiple genetic and environ-
mental factors encompassing many cell types (Nestler and Hy-
man, 2010; Petrik et al., 2012). Governing views onMDD etiology
propose that in response to environmental stimuli such as stress,
the normally optimized activities of specific brain circuits are
altered as a result of maladaptive molecular and cellular changes
(Mayberg, 2003; Ressler and Mayberg, 2007). Many studies
have directly linked stress signals to neuronal malfunction, but
there have been only a few investigations into the role of glia in
this process. Glial cell loss, alongwith glutamate-related deficits,
has been correlated withMDD pathophysiology. Reduced astro-
cyte (GFAP+) cell numbers have been shown both in animal
models of depression and in postmortem analysis of MDD pa-
tients (Banasr and Duman, 2008; Ongu¨r et al., 1998). Nonethe-
less, so far, there have been no studies that have defined the pre-
cise mechanistic roles of discrete glial subtypes and their
molecular, cellular, and physiological correlates, either in rodent
models or in postmortem patient samples of MDD. (Schroeter
et al., 2010).
Here, we report a role for NG2 glia in the maintenance of CNS
physiology. We show that pharmacologically induced loss of
NG2 glia in the prefrontal cortex (PFC) is followed by astrocyticNeuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc. 941
Figure 1. NG2CRE/iDTR, a Model of NG2 Glial Cell Ablation
(A) Paradigm used for NG2 glial cell ablation in the iDTR adult mouse brain using systemic Diphtheria Toxin (DT) administration. DT (50 ng/ul) was injected once
daily for 7 days; days post DT (dpDT).
(B) Representative images and quantification of depletion efficiencies in different brain regions including cortex, hippocampus, subcortical white matter and
striatum. Arrows, NG2+ glial cells.
(C) NG2 glial cell numbers in different cortical regions of control and iDTR mice at 7DT.
(legend continued on next page)
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and neuronal glutamate abnormalities that have previously been
reported inMDD and its rodentmodels (Banasr et al., 2010; Yuen
et al., 2012) and, in this setting, lead to the acquisition of depres-
sion-like behaviors. We also show that chronic social stress
decreases NG2 glial proliferation, and cell number. Finally, we
show that the ensuing decrease in production of NG2 glia-
derived factors (i.e., FGF2) during chronic stress may underlie
the glutamate abnormalities and resulting maladaptive behav-
ioral phenotype.
RESULTS
Validation of the NG2CRE/iDTR Mouse Line for Exploring
Consequences of NG2 Glial Ablation
To directly explore potential roles for NG2 glia in adult CNS phys-
iology, we developed a transgenic line in which NG2 glia can be
transiently depleted (‘‘NG2CRE/iDTR’’ mice; ‘‘iDTR’’; Birey and
Aguirre, 2015). In this mouse line, the diphtheria toxin (DT) recep-
tor (DTR; Rosa26-stop-DTR) is under the control of the NG2
promoter (Buch et al., 2005), rendering NG2 glia susceptible
to death when DT is administered. In the iDTR mice with a
ROSA26-stop-YFP reporter cassette, we did not detect any
YFP+ neurons (NeuN+ cells) or astrocytes (GFAP+ or GS+ cells)
in the prefrontal cortex (PFC); rather, virtually all of the YFP+ cells
were NG2 glia (YFP+ NG2+ or YFP+ Olig2+ cells), with small
numbers of mature OLs (YFP+CC1+ cells, which are generated
from NG2 glia), and a small percentage of NG2+ pericytes
(SMA+) (see Figure S1A available online). YFP+ expression in
the striatum, which was previously reported to have high
NG2 glial-derived astrocyte output in development (Zhu et al.,
2011), similarly showed no coexpression with astrocyte-lineage
markers (Figure S1B). To rule out the presence of DTR-express-
ing astrocytes, we prepared primary cortical cultures from
PFC obtained from the iDTR mice (Figure S1C). The cells were
treated once daily with DT (50 ng/ml) for 7 days, following
which GFAP expression levels and GFAP+ cell numbers were
analyzed. No differences were discernable between control
(NG2CRE only : ‘‘CTRL’’) and iDTR cells, confirming that the astro-
cytes in the adult iDTR brain do not express DTR and are there-
fore not susceptible to DT (Figures S1D and S1E).
For the ablation experiments, we adapted a previously estab-
lished DT administration paradigm (Buch et al., 2005): DT (50 ng)
was injected intraperitoneally (i.p.) once daily into the adult mice
(postnatal day 60; P60) for 7 days (each injection day termed ‘‘1–
7DT’’; Figure 1A). Using this approach, we achieved a reduction
in NG2 glial density of 60%–75% in the cerebral cortex and
25%–40% in the hippocampus and subcortical white matter
(SCWM) at 7DT (Figure 1B). Most of the cortical regions were
equally affected (Figure 1C). As expected, the DT administration
did not affect astrocytic or neuronal densities (Figure 1D).We de-
tected a small reduction of mature OL numbers (CC1+ cells);(D)NG2glia (PDGFRa+), neuron (NeuN+), astrocyte (glutaminesynthase;GS+), and
(E) Representative confocal images of MBP immunostaining from control and iD
(F) Protein extracts from the PFC were used to analyze total expression levels of
(G) The number of mature oligodendrocytes is rapidly replenished during the
(BrdU+CC1+ cells) at 5 days after 7DT (5dpDT). Error bars, mean ± SEM (*p < 0
See also Figures S1–S3.however, this reduction did not lead to demyelination at 7DT (Fig-
ures 1E and F). Furthermore, lineage tracing analysis using a
long-term 5-bromo-20-deoxyuridine (BrdU) administration proto-
col (Aguirre and Gallo, 2007) demonstrated that the number of
mature OLs in the PFC (BrdU+ CC1+ cells) returned to normal
levels at 5–7 days post DT (dpDT) (Figure 1G). In summary, these
findings validated NG2CRE/iDTR as a useful tool to specifically
and robustly ablate NG2 glia in the adult brain without affecting
other neural cell types.
NG2 Glia Ablation Does Not Affect Brain Vasculature or
Induce Major Inflammation
NG2 is also expressed in pericytes in the adult CNS (Ozerdem
et al., 2001), which are essential for the maintenance of vascula-
ture cytoarchitecture and the blood-brain barrier (BBB) (Dane-
man et al., 2010). A small subset of the YFP+ cells were found
to express the pericyte marker SMA (YFP+ SMA+ cells) in the
cortices of NG2CRE/iDTR/YFP mice (Figure S2A). DT administra-
tion might therefore kill these cells along with the NG2 glia,
adversely affecting brain vasculature and/or the BBB. However,
the characterization with anti-SMA, anti-laminin, and anti-PE-
CAM antibodies to assess the vascular cellular composition
demonstrated that there were no apparent differences between
the CTRL and the iDTR mice at 7DT or any other timepoint (Fig-
ures S2A and S2B). We next performed tail-vein injections of
FITC-conjugated dextran (40 kDa) at 7DT to quantitatively
assess the cortical vascular network (McCaslin et al., 2011),
and found that there were no differences in the vasculature
area coverage, total vasculature length per area and number of
branchpoints in the PFC of iDTR mice at 7DT (Figures S2C and
S2D). In addition, NG2 immunostaining of dextran-injected
brains indicated that while NG2 glia (NG2+ glia FITC-Dextranneg
cells; arrows) were absent in the PFC at 7DT, while NG2+ peri-
cytes enwrapped around the vasculature (NG2+ FITC-Dextran+
cells; arrowheads) were preserved at 7DT (Figure S2E). Finally,
we used the dye Evans blue to examine BBB integrity. No traces
of the dye were detected in the brain parenchyma of either the
CTRL or iDTR mice at 7DT (Figure S2F).
We anticipated that we would observe microglial activation in
response to the significant NG2 glial cell loss, since one of the
roles microglia undertake is to clear cell debris. Microglial
(Iba1+ cells) morphological changes that were detected in the
PFC of iDTRmice at 7DT returned to resting levels at 7dpDT (Fig-
ure S3A). The transcript levels at 7DT of several proinflammatory
cytokines were not significantly elevated (Figure S2B). To selec-
tively assess microglial cytokine levels following NG2 glial abla-
tion, we isolated RNA from microglia (CD11b+ cells) isolated by
FACS from thePFCs of CTRL and iDTRmice at 7DT (Figure S3C).
Similar CD11b+ cell numbers and cytokine expression levels be-
tween CTRL and iDTR confirmed the absence of microglial acti-
vation on a molecular level in the iDTR mice at 7DT (Figures S3Dmatureoligodendrocyte (CC1+) numbers in thePFCof control and iDTRat 7DT.
TR mice at 7DT.
MBP and MOG at 7DT.
DT paradigms as assessed by the newly formed mature oligodendrocytes
.05, **p < 0.01; t-test) n = 5–7 per group. Scale bars, 40 mm.
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and S3E). Taken together, we conclude that NG2 glial ablation
does not disturb the brain vasculature or cause significant micro-
glial activation and pro-inflammatory response, validating our
iDTR system as a tool for exploring roles for NG2 glia in the
adult CNS.
NG2 Glia Ablation Adversely Affects Glutamatergic
Signaling in Excitatory Pyramidal Neurons
Morphological and physiological interactions between NG2 glia,
and astrocytes and neurons, such as extension of glutamatergic
synapses onto NG2 glia in the hippocampus (Bergles et al.,
2000), are well described (reviewed in Wigley et al., 2007).
Although it is now evident that neurons and astrocytes can elicit
NG2 glia migration, proliferation, and lineage progression (Hill
et al., 2014; Mangin et al., 2012; Ziskin et al., 2007), it has
remained unknown whether NG2 glia, in turn, affect astrocytic
and neuronal functioning.
To explore the influence of NG2 glia on excitatory neuro-
transmission, we assessed the postsynaptic glutatmate recep-
tor function by recording miniature excitatory postsynaptic
currents (mEPSC) from pyramidal excitatory neurons in the
PFC slices, from pyramidal excitatory glutamatergic following
NG2 glial ablation. At 7DT, the mEPSC amplitude was
decreased and the decay increased, whereas the frequency
was unchanged (Figures 2A–2D). No such changes were
observed in the dorsal striatum and the frequency and decay
were increased in the somatosensory cortex, suggesting
regionally heterogeneous responses of glutamatergic neuro-
transmission to NG2 glial loss (Figure S4). Consistent with the
altered mEPSC dynamics in the PFC, levels of membrane-
bound glutamate receptor 1 (GluR1), but not GluR2, were
decreased, although the total levels of both subtypes were un-
changed (Figures 2E and 2F). GluR1 pan-phosphorylation,
which is known to modulate the receptor’s synaptic presence
(Lee et al., 2003), was also decreased (Figure 2G), along with
the levels of phosphorylated PKC and CaMKII, which are
upstream regulators of GluR1 membrane translocation and
phosphorylation (Brooks and Tavalin, 2011) (Figures 2H and
2I). The levels of vesicular glutamate transporter VGLUT1 and
postsynaptic density marker PSD-95 were unchanged, sug-
gesting the lack of a systemic insult on the excitatory synapse
(Figures 2H and 2I). Our analysis showed that NG2 glia loss in
the PFC adversely affects postsynaptic, phosphorylation-
dependent glutamate receptor trafficking and the associated
glutamatergic neurotransmission.
NG2 Glia Ablation Suppresses Astrocytic Glutamate
Uptake
One of the crucial astrocytic dysfunctions that adversely
affect excitatory signaling in neurons is sub-optimal clearance
of excess glutamate from the synaptic cleft due to decreased
expression of the glutamate transporters GLT-1 and GLAST,
which can ultimately result in excitotoxicity and maladaptive
neural activity (Go´mez-Gala´n et al., 2013; Hashimoto et al.,
2007; Miguel-Hidalgo et al., 2010).
To test whether aberrant glutamatergic neurotransmission in
the PFC following NG2 glia loss is partly mediated by astrocytic
dysfuction, we analyzed if NG2 glia modulate astrocytic gluta-944 Neuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc.mate uptake. For this, we measured levels of uptake of the
non-metabolizable glutamate analog [3H]-D-aspartate, using
both gliosomal preparations from fresh PFC extracts and pri-
mary cortical cultures harvested from the PFCs of CTRL and
iDTR mice at 7DT (Figure 3A). Both methods revealed a
30%–40% decrease in [3H]-D-aspartate uptake levels in the
iDTR mice (Figure 3B). In accordance, intracellular accumula-
tion and decreased membrane expression of GLAST were
observed in the cortical mixed-culture preparations obtained
from the PFC of iDTR mice at 7DT (Figure 3C). Total GLAST
and GLT-1 protein levels were also decreased along with
expression of pSTAT3, which regulates glutamate transporter
expression (Raymond et al., 2011) (Figure 3D). GLAST levels
and [3H]-D-aspartate uptake were similarly affected in the hip-
pocampus of iDTR mice at 7DT, but not in the striatum (Figures
3E and 3F), mirroring the regions with highest ablation effi-
ciencies. These results point to glutamate uptake as a major
output of CNS homeostasis that is compromised both in stress
pathology and after NG2 glial loss. Taken together, these find-
ings underscore roles of NG2 glia in CNS physiology, loss of
which disturbs glutamate-associated astrocytic and neuronal
functions.
NG2 Glia Loss Predisposes to a Depressive-like State
in Mice
Given the extensive loss of function in glutamatergic signaling
and extracellular glutamate clearance in the neurons and astro-
cytes following NG2 glial loss, we next investigated whether
these deficits translate into behavioral aberrations. Indeed,
such glutamate-related astrocytic and neuronal functions
have consistently been implicated in both chronic stress
models and MDD pathophysiology (Almeida et al., 2010;
Bechtholt-Gompf et al., 2010; Hashimoto et al., 2007; Miguel-
Hidalgo et al., 2010; Caudal et al., 2010); e.g., chronic stress
induces a persistent potentiation of glutamate receptor mem-
brane trafficking and glutamatergic transmission in the rat
PFC (Yuen et al., 2012). Yet, little is known about whether
glia plays any roles in the manifestation of such maladaptive
outcomes.
To this end, we employed behavioral tasks to examine
whether ablation of NG2 glia drives depressive-like behaviors
in mice, namely anxiety-like (measured by open field [OF] and
elevated plus maze tests [EPM]), anhedonia-like (measured by
sucrose preference test [SP]), and social avoidance behaviors
(measured by social interaction test [SI]). We observed de-
creases in the center entries and open-arm entries over total
path traveled in the OF (Figures 4A and 4B) and EPM, respec-
tively, by the iDTR mice at 7DT (Figure 4B). Anhedonia-like
behavior was also observed in the iDTRmice at 7DT as indicated
by the decrease in the sucrosewater preference over regular wa-
ter (Figure 4B). Social avoidance was examined using a sub-
threshold ‘‘microdefeat’’ paradigm (Figure 4C), a 1-day defeat
protocol, which reveals susceptibility-promoting interventions,
since it, by itself, is not sufficient to induce susceptibility in
wild-type mice (Christoffel et al., 2011; Golden et al., 2013).
Following the microdefeat paradigm, the average social interac-
tion score (SI score) for the iDTR group was reduced by about
60% (Figure 4D). These results indicate that the induced loss
Figure 2. NG2 Glia Ablation Causes Deficits in the Glutamatergic Synaptic Transmission in the PFC
(A and B) Sample recordings (25 s) of miniature EPSCs (mEPSC) taken from PFC pyramidal neurons (n = 23–5 per group). (A) Sample recordings at higher
magnification lasting 2.5 s and (B) individual mEPSC lasting 250 ms.
(C) Histogram of mEPSC amplitude. Insert, a percent distribution of mEPSC amplitudes.
(D) Average amplitude (left), decay (middle), and frequency (right) mEPSCs.
(E and F) Membrane translocation of glutamate receptor 1 (GluR1) and GluR2.
(G–I) GluR1 serine phosphorylation (G) and total protein expression levels of CaMKII, pPKC, vGLUT1, and PSD95 (H) quantified in (I). Error bars, mean ± SEM
(*p < 0.05; t-test); n = 3–4 per group unless indicated otherwise.
See also Figure S4.of NG2 glia in the cerebral cortex and hippocampus suffices to
predispose to a battery of depressive-like behavioral symptoms.
Focal Ablation of NG2 Glia in the PFC Induces
Depressive-like Behavioral Deficits
Although there exists regional restrictions to the NG2 glia abla-
tion by systemic (i.p.) DT administration (Figure 1B), the cellular
loss is widespread throughout some areas in the CNS and thus
does not identify the brain regions critical for eliciting the emer-gence of depressive-like behavioral deficits. To investigate
whether restricting NG2 glial loss to a pathologically relevant
brain region would suffice to create the behavioral deficits,
we focally infused DT (5 ng/day for 2 days) using cannulas im-
planted directly into the PFC to spatially restrict NG2 glial abla-
tion to this region of the brain (Figure 4E). Using this approach,
we were able to achieve NG2 glial loss locally in the PFC
without affecting the surrounding regions such as the adjacent
motor cortex (Figures 4F and 4G). Furthermore, there were noNeuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc. 945
Figure 3. NG2 Glia Ablation Leads to
Impaired Glutamate Transporter Expres-
sion and Glutamate Uptake Deficit in
the PFC
(A) Schematics of experimental protocol used for
3H-D-aspartate uptake assays.
(B) 3H-D-aspartate uptake assayed in CTRL and
iDTR PFC gliosomes and in primary cortical
astrocyte cultures at 3DT and 7DT; n = 8–10 per
group.
(C) Intracellular and cell membrane-bound levels
of GLAST from PFC CTRL and iDTR of in primary
cortical astrocyte cultures at 7DT.
(D) Protein expression levels of glutamate trans-
porter GLAST, GLT-1 and pSTAT3 in the PFCs of
CTRL and iDTR mice at 7DT.
(E) 3H-D-aspartate uptake assayed in CTRL and
iDTR hippocampal and striatal gliosomes at 7DT.
(F) Protein levels of GLAST in the hippocampus
and striatum at 7DT. Error bars, mean ± SEM
(*p < 0.05). n = 4–5 per group unless indicated
otherwise.major changes in other cell types in number and function,
including astrocytes, microglia, mature OLs, and pericytes (Fig-
ures 4F–4H). PFC-focal ablation of NG2 glia recapitulated anx-
iety- and social avoidance-like behaviors, but not anhedonic
behavior (Figures 4I and 4J), raising the possibility that the
loss of NG2 glia in other areas (i.e., hippocampus; Snyder
et al., 2011) might be responsible for the anhedonic behavior.
Together, our data demonstrate that PFC-specific loss of
NG2 glia suffices to trigger behavioral abnormalities largely
comparable to those observed in the systemically ablated
iDTR mice.
Ablating NG2 Glia Using an Independent Approach
Similarly Disturbs Glutamate Signaling and Uptake, and
Induces Depressive-like Behavior
To further address the possibility of an off-target transgenic an-
imal-specific effect through use of the iDTRmice, we used an in-
dependent, tamoxifen-inducible CRE promoter, PDGFRaCRETM,
to drive DTR expression in the NG2 glia (PDGFRaCRETM/iDTR/
YFP mice). iDTR/YFP expression in PDGFRaCRETM mice was
induced by daily i.p. injections of tamoxifen from P8 to P12. DT
(100 ng; Figure S5A) was then administered as before approxi-
mately 7 weeks later. The great majority of PDGFRa+ cells coex-
pressed YFP, suggesting a good recombination efficiency in the
adult PFC (Figure S5B). DT administration reduced the NG2 glial
density in the PFC by 50% at 7DT (Figures S5B and S5C). We
then asked whether the functional consequences of NG2 glia
ablation observed in the iDTR mice are recapitulated using this
mouse line. We thus examined astrocytic glutamate handling
and found that [3H]-D-aspartate uptake (Figure S6D), andmolec-946 Neuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc.ular signaling elements involved in the
regulation of transport were decreased
(Figure S5E), and observed anxiety- and
anhedonia-like deficits as well as social
avoidance (Figures S6F and S6G). Taken
together, these findings confirm ourearlier systemic and focal ablation outcomes, ruling out the pos-
sibility of transgenic line-specific bias as an explanation for the
observed changes in glutamate uptake and molecular mecha-
nisms driving behavioral deficits after NG2 glia ablation.
Restoration of NG2 glia Density Correlates with the
Rescue of the Molecular, Cellular, and Behavioral
Abnormalities
We next examined whether NG2 glia density recovers after the
ablation event. To assess this, we marked newly generated
NG2 glia using BrdU administered in drinking water after
completion of the DT administration at 7DT. NG2 glia started to
repopulate the PFC at 7 dpDT Figure 5A), and their numbers
became comparable to those in CTRL mice by 21dpDT. The
source of the newly generated NG2 glia in the PFC was prolifer-
ative local resident NG2 glia that had escaped depletion, as
many of the NG2+BrdU+ glia in the regions surrounding the
areas of depletion were Ki67+ at 7dpDT and 21dpDT (6 ± 3.3
10x6 um3 in the iDTR mice in comparison to 1 ± 1.5 cells 3 106
um3 in the CTRL mice; Figure 5A).
In parallel to the NG2 glia repopulation, virtually all of the mo-
lecular, cellular and behavioral measures similarly recovered to
CTRL levels by 21dpDT (Figure 5), including [3H]-D-aspartate
uptake (Figure 5B), glutamate transporter expression (Fig-
ure 5C), somatosensory cortex and PFC mEPSCs, (Figures
5D–5G and S4), membrane localization and phosphorylation sta-
tus of GluR1 and pPKC (Figures 5H and 5I), and behavior (Fig-
ures 5J and 5K). Taken together, NG2 glial repopulation rescues
the molecular, cellular, and behavioral ablation-specific CNS
deficiencies.
Figure 4. NG2 Glia Ablation Causes Depressive-like Behaviors in Mice
(A) Open field activity.
(B–D) Behavioral analyses at 7DT (n = 12–14 per group; t test; OF, open field test; EPM, elevated plus maze; SP, sucrose preference test; SI, social interaction
test). (B) Center entry measures normalized to total distance traveled assessed OF. Percent open arm entry frequencies over all entries assessed by EPM. A total
of 1% sucrose water preference assessed by SF. (C) Schematic for subthreshold microdefeat protocol. (D) Average SI scores following microdefeat.
(E–G) Paradigm for local NG2 glia ablation in the PFC. Representative images (F) and cell number quantification (G) of NG2 glia, mature oligodendrocytes (GSTPi+
cells), astrocyte (GS+cells), andmicroglia (Iba+cells) in thePFCandmotor cortexafterNaClorDT infusionviacannula into thePFCof iDTRmice (n=4pergroup; t test).
(H) Protein expression levels of astrocytes (GFAP), function-associated molecular markers for astrocytes (GLAST, GLT-1), mature oligodendrocytes (CNPase;
myelin MBP), pericytes (PDGFRb) and microglial cell activation (iNOS) after DT infusion in the PFC using cannula implanted in this brain region.
(I) Open field activity after NaCl or DT infusion.
(J) Behavioral analyses performed after acute focal NG2 ablation (n = 11–16 per group; t test). Error bars, mean ± SEM (*p < 0.05, **p < 0.01). Scale bar, 40 mm.
See also Figure S5.Reduced NG2 Glia Density following Chronic Social
Stress in Mice
The prominent behavioral disturbances and MDD-related gluta-
matergic deficits in neurons and astrocytes (Almeida et al., 2010;
Bechtholt-Gompf et al., 2010; Caudal et al., 2010; Yuen et al.,
2012) observed following NG2 glial ablation led us to question
whether NG2 glia density is reduced during the emergence of
depressive-like behaviors. Chronic stress is a primary predictorof various cognitive and emotional disturbances in neuropsychi-
atric disorders, such as MDD and post traumatic stress disorder
(PTSD). Based on this idea, we utilized a stress-based rodent
model of MDD, the Social Defeat Stress Paradigm (SDSP)
(Golden et al., 2011), to study the relationship between chronic
social stress and NG2 glial density. In the SDSP model, adult
mice are subjected to repeated bouts of physical aggression
(‘‘defeats’’) from larger ‘‘bully’’ mice. About 60% of the miceNeuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc. 947
Figure 5. Repopulation of NG2 Glia Density
in the PFC after Their Depletion Is Associ-
atedwith the Recovery ofMolecular, Physio-
logical, and Behavioral Stress-Related Defi-
ciencies
(A) Images and cell quantification of newly gener-
ated NG2 glia at 7dpDT and 21dpDT. BrdU
(1 mg/mL) was giving in the drinking water after the
last DT injection.
(B) 3H-D-aspartate uptake in the PFC of control and
iDTR at 21dpDT.
(C) Protein expression levels of pSTAT3, GLAST,
and GLT-1 in the PFC of control and iDTR at
21dpDT.
(D) Sample recordings (25 s) of miniature EPSCs
from pyramidal neurons in the PFC. (CTRL, n = 10;
iDTR, n = 15; t test).
(E) Sample recordings at higher magnification
lasting 2 s and individual mEPSC.
(F) Histogram of mEPSC amplitude. Inset, percent
distribution of mEPSC amplitudes.
(G) Average amplitude, decay, and frequency.
(H and I) Serine phosphorylation (H) and levels of
intracellular and membrane-bound GluR1 (I) in the
PFC at 21dpDT.
(J and K) Behavior analysis at 7dpDT and 21dpDT
(n = 16–18 per group; two-way repeated-measures
ANOVA (for OF analysis) and t test). (J) Open field
activity and percent center entry frequencies over
total distance traveled at 7dpDT and 21dpDT. (K)
Percent open arm entry frequencies over all entries,
1% sucrose consumption, and average SI scores
following microdefeat for behavioral analyses. Er-
ror bars, mean ± SEM (*p < 0.05). n = 4–5 per group
unless indicated otherwise. Scale bar, 40 mm.that are subjected to social stress display social avoidance and
other associated behavioral deficits (and are termed ‘‘suscepti-
ble’’), whereas the nonresponding mice, which are termed
‘‘resilient,’’ do not, modeling the heterogeneity in individual re-
sponses to stress in the human population (Krishnan and
Nestler, 2011).
Using the SDSP model, we examined NG2 glial densities in
two of the regions known to be intimately involved in MDD path-
ophysiology, the prefrontal cortex (PFC) and the hippocampus
(Campbell et al., 2004; Cotter et al., 2002). Cell density analyses
were performed at 4 days of defeat (4d), 8 days of defeat (8d),
and 8 days of defeat plus 10 days of recovery (8d+10d) (Fig-
ure 6A). Quantification of PDGFRa+ cells (as a marker for NG2
glia) indicated decreased NG2 glial density in the CA1 region of
the hippocampus in susceptible mice compared to control and
resilient animals at 4d, 8d, and 8d+10d (Figure 6B). The same
analysis in the PFC, however, showed a significant increase in
density at the early defeat time-point (4d) in the susceptible
mice, but then decreased density at 8d and 8d+10 (Figure 6C).
In contrast, NG2 glia density was not altered in the somatosen-
sory cortex, dorsal striatum and other regions of hippocampus
(data not shown), areas that are not directly implicated in
the early pathogenesis of MDD. Together, these data suggest
a very rapid and region-specific response to stress, as well as
a differential response to acute, instead of chronic, stress in
the PFC.948 Neuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc.Given the highly active proliferation profiles of NG2 glia in the
normal adult CNS (Hughes et al., 2013; Psachoulia et al., 2009),
we next asked whether the decreased density of NG2 glia could
be attributed to reduced proliferative capacity after chronic
stress. The fluctuations observed in the numbers of proliferating
NG2 glia (PCNA+NG2+ cells) in the PFC mirrored the dynamic
changes in density observed throughout the defined defeat
time points (Figures 6D and 6E), suggesting that the shortage
of NG2 glia in susceptible animals could be a consequence of
decreased rates of proliferation. We next sought to pinpoint
the upstream stress-responsive signaling elements that might
mediate NG2 glia proliferation. A candidate pathway involves
GSK3b, as it has been previously implicated both in the patho-
physiology of MDD (Jope and Roh, 2006) and in the regulation
of NG2 glial proliferation in a mouse model of hydrocephalus
(Carter et al., 2012). Reduced numbers of NG2 glia co-express-
ing pGSK3b (pGSK3b+ PDGFRa+ cells) in the PFC of suscepti-
ble animals at 8d (Figure 6F) indicated that reductions in
GSK3b phosphorylation may underlie the suppressed NG2 glial
proliferation following chronic stress.
To inquire whether genetic propensity to depression is also
correlated with NG2 glial density, we used a congenital rodent
model of depression, congenitally learned helplessness (cLH).
cLH rats were selectively bred for the phenotype of learned
helplessness, which is quantifiable as significantly reduced
lever pressing to escape electrical shocks (Henn and
Figure 6. Reduced NG2 Glia Density in Animal Models of Depression and MDD Subjects
(A) Experimental protocol for social defeat stress paradigm (SDSP) and schematic of anatomical brain regions investigated: prefrontal cortex (PFC), and Prelimbic
(PrL) and infralimbic (IL) regions of the CA1 region of hippocampus.
(B–F) Representative images (B) and cell quantification (C) of PDGFRa+ cells in CA1 and PFC at 4d, 8d, and 8d+10d of susceptible animals (SUS) compared to
resilient (RES) mice (n = 5–6 per group; t test). Representative images (D) and cell quantification (E) of proliferation dynamics of NG2 glial cells (NG2+ PCNA+ cells)
in the PFCof control, RES, and SUSmice at 4d, 8d, and 8d+10d. (n = 4 per group). (F) Quantification of PDGFRa+ pGSK3b+ cells of control, RES, and SUSmice in
the PFC at 8d (n = 4 per group).
(G) Representative images and cell number of PDGFRa+ cells in PFCs of adult congenitally nonlearned helpless (cNLH) and learned helpless (cLH) rats (n = 4 per
group; t test).
(legend continued on next page)
Neuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc. 949
Vollmayr, 2005). A reduction in NG2 glia density was observed
in the PFC of helpless (cLH), but not in non-helpless (cNLH)
rats (Figure 6G), indicating that NG2 glia cell loss also corre-
lates with endogenously presented depressive-like behavior
in rodents, even in the absence of an acute or chronic stress
stimulus.
NG2 Glia Density Is Reduced in the Frontal Cortices of
MDD Patients
To investigate whether our findings in rodent models of stress
might be clinically relevant, we quantified NG2 glial density in
human subjects with MDD. We obtained post-mortem frontal
cortex samples of MDD subjects from two independent brain
tissue banks (control; n = 8, MDD; n = 12). PDGFRa protein
levels in the frontal cortices of MDD subjects were significantly
reduced compared to those found in age-matched controls
(Figure 6H).
We then examined NG2 glia in situ in the frontal cortices
of MDD subjects. We focused on cells with typical stellate
morphology of NG2 glia—i.e., having multiple thin, branched
processes that colocalized with PDGFRa, in order to exclude
NG2+ pericytes from our analysis (Ozerdem et al., 2001) (Fig-
ure 6I). We detected reduced cell numbers of NG2 glia in the
frontal cortices of MDD subjects as compared to age matched
control subjects, supporting our western blot analyses (Fig-
ure 6J). Taken together, our data indicate that NG2 glial density
is reduced as a consequence of chronic social stress inmice and
in the post-mortem tissue of MDD subjects, suggesting that loss
of NG2 glia is a clinically relevant phenomenon in stress-related
disorders. Further confirmation of NG2 glial cell loss and how it
interacts with certain variables (e.g., antidepressant use, age,
sex) in MDD awaits future studies with larger cohorts of MDD
patients.
NG2Glia-Secreted FactorsModulate Key Astrocytic and
Neuronal Functions Compromised by NG2 Glia Loss in
the PFC
Glia secrete a plethora of factors including growth factors, neu-
rotrophins, and cytokines that help regulate neuronal transmis-
sion. For example, astrocyte-secreted ATP has been proposed
to be an anxiolytic, as genetically blocking its release in mice
causes depressive-like behaviors (Cao et al., 2013); similarly,
glial-released TNFa has causally linked to hippocampus-medi-
ated long-term memory (Han et al., 2013). To investigate
whether NG2 glia similarly modulate neuronal and astrocytic
functions in a paracrine fashion, we generated media enriched
in NG2 glia-secreted factors (NG2 glial-conditioned media;
‘‘NG2CM’’) by FACS-isolating YFP+ cells from the PFC of
NG2CRE/YFP mice and culturing them for 3 days in growth fac-
tor-free media containing 2% FBS. PDGFRa+ cells represented
about 85%–88% of the FACS-isolated YFP+ cells (Figure 7A).(H) Protein levels of PDGFRa from PFCs of the control and MDD subjects. Boxp
controls (CTRL n = 8, MDD n = 12; paired t test).
(I) Characterization of human NG2 glial cells in the frontal cortex gray matter c
pericytes.
(J) Representative images and cell number (percent over total DAPI+ nuclei) of N
**p < 0.01). Error bars, mean ± SEM. Scale bars, 40 mm; Scale bars in (F), 20 mm
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or the NG2CM. NG2CM promoted GLAST membrane transloca-
tion (Figure 7B) and phosphorylation of STAT3 (Figure 7C) in as-
trocytes in a time-dependent manner. Similarly, NG2CM
increased luciferase activity in astrocytes transfected with a
GFAP-luciferase reporter construct containing STAT3 binding
sites upstream of the GFAP-promoter (Asano et al., 2009; Fig-
ure 7D), and it stimulated GluR1 and PKC phosphorylation in
primary neurons (Figure 7E). These results indicate NG2 glia-
secreted factors support critical astrocytic and neuronal func-
tions and hence that deficiency of these factors could mechanis-
tically underlie the astrocytic and neuronal deficits observed
following NG2 glial ablation.
NG2 Glial Secretion of FGF2 in the PFC Is
Downregulated following Chronic Social Stress
Next, in order to identify NG2 glia-secreted factors that might
play a role in the development of susceptibility to depressive-
like behavior, we isolated NG2 glia at 8d+3d from the PFC of sus-
ceptible, resilient, and control mice by FACS and quantified
mRNA expression levels of an array of growth factors, neurotro-
phins, and cytokines using a gene-based array (The Mouse Neu-
rotrophin and Receptors RT2 Profiler PCR Array; QIAGEN) (Fig-
ures 8A, 8B, and S6). Some of the top hits included secreted
factors that have been previously associated with MDD (Fig-
ure 8C). Among these, FGF2 was the only factor that was signif-
icantly reduced in the NG2 glia isolated from susceptible
compared to both control (fold change = 16) and resilient
(fold change = 8) mice (Figures 8C and S6; Table S2). FGF2
has previously been strongly correlated in the pathophysiology
of MDD and is downregulated in chronic stress models (Elsayed
et al., 2012; Perez et al., 2009). Further in this context, FGF2 has
been observed to regulate several neuronal and astrocytic func-
tions that were also dysregulated in our system after NG2 glia
depletion, namely GluR1- and GLAST-related glutamatergic
functions (Figure 8C; see in-figure references). Our analysis
here suggested that FGF2 secreted by NG2 glia could be a crit-
ical factor that modulates CNS homeostasis and is perturbed
during chronic stress.
NG2 Glia-Specific Knockdown of FGF2 Suffices to
Induce Depressive-like Behaviors
Finally, we sought to determine whether the mechanism un-
derlying the loss of NG2 glia predisposing to anxiety-like
behavior in mice is mediated by FGF2. To test this hypothe-
sis, we knocked down FGF2 specifically in the NG2 glial
cells in the PFC and performed behavior analysis. To accom-
plish the FGF2 knockdown, we used NG2CRE mice and a
CRE-dependent flox/flox shRNA lentiviral system (Ventura
et al., 2004) to stably express shRNA directed to the mouse
FGF2 after CRE recombination in NG2 glial cells. Usinglot of PDGFRa expression levels in MDD subjects and age- and sex-matched
haracterized using PDGFRa immunostaining. Arrows, NG2 glia; Arrowheads,
G2 glia in the PFCs of control, and MDD subjects. Arrows, NG2 glia (*p < 0.05,
.
Figure 7. NG2 Glia-Secreted Factors
Mediate Astrocytic and Neuronal Functions
(A) Schematics of experimental paradigm and
representative image of post-FACS cells indicating
sort purity (85%–90% of all DAPI cells were
PDGFRa+).
(B) GLAST cellular localization at different time
points of stimulation with 2% fresh medium (FM)
or NG2 conditioned media (NG2-CM) in primary
cortical astrocytes.
(C) Time course of phosphorylation of STAT3
(pSTAT3) in response to 2%FM and NG2CM in
primary cortical astrocytes.
(D) GFAP-Luciferase reporter assay activity in pri-
mary cortical astrocytes in response to 2% FM or
NG2CM.
(E) Time course of PKC and pGluR1 phosphoryla-
tion in response to 2% FM and NG2CM in primary
hippocampal neurons. Error bars, mean ± SEM
n = 4–5 per group (*p < 0.05; two-way ANOVA).this approach, EGFP is initially expressed in all infected
cells, but then turns off after the NG2 promoter-mediated
recombination that simultaneously turns on the expression
of shRNA against mouse FGF2 (Figure S7; see Experimental
Procedures).
We cloned four different shFGF2 sequences into the pSico
plasmid (shFGF2-1 - shFGF2-4; see Experimental Procedures
for the shFGF2 sequences) in addition to a control scramble
construct. To validate and optimize the shFGF2 viral constructs,
we utilized NG2 glial cell-enriched cultures derived from the brain
cortices of adult NG2CREpos mice and NG2CREneg mice (Fig-
ure S7a). Cell cultures were processed at several days of infec-
tion (dpi) and processed for either FACS or immunocytochem-
istry analysis to detect FGF2 mRNA and protein levels,
respectively (Figure S7A). Note that at 32 hr in vitro (hiv),
PDGFRa+ cells are EGFP+, while at 3DIV they were PDGFRa+
EGFPdim and at 5DIV virtually all the PDGFRa+ cells were
EGFPneg (Figure S7B). Hence, we FAC-sorted PDGFRa+EGFP+,
PDGFRa+EGFPneg, and PDGFRanegEGFP+ cell populations to
determine the efficiency of FGF2 downregulation in NG2 glial
cells (Figure S7C). The shFGF2-1 construct achieved the highest
efficiency of FGF2 downregulation in NG2 glia (Figures S7D–
S7F; see also Experimental Procedures) as compared with
shFGF2-2 and scramble constructs. Therefore we used the
shFGF2-1 construct in all our functional and behavioral experi-
ments. FGF2 downregulation in NG2 glia was further confirmed
post-FACS by analyzing FGF2 fluorescence levels in PDGFRa+
EGFPneg cells from shFGF2-1 versus scramble construct (Fig-
ure S7F). This analysis thus validated our approach for NG2-
glia-specific knockdown of FGF2.
We next knocked down FGF2 expression in NG2 glia in the
PFC of NG2CRE mice and assessed behavioral tasks associated
with depressive-like behavior (see also Supplemental Experi-
mental Procedures). NG2CREneg (wild-type) mouse was then
used to establish the conditions to target NG2 glial cells in thePFC using this lentiviral system (Figure 8D). In the PFC of these
animals, a large percentage of the PDGFRa+ cells are targeted
with the pSico lentiviral system (Figure 8E, top panel; arrows).
Characterization of EGFP+ cells at this time points showed
that a large percentage of these cells co-expressed PDGFRa
(53 ± 6 PDGFa+ EGFP+ cells / EGFP+ cells; Figure 8E, top
panel arrows). We next confirmed that shFGF2-1 resulted in
transfection of NG2 glia in the PFC of NG2CREpos animals, as
we did not detect any PDGFRa+ cells within the EGFP+ cells
at this time points (Figure 8E, bottom panel arrows). Under
those conditions, we also detected EGFP+ cells coexpressing
the neuronal and astrocytic markers NeuN and GFAP, res-
pectively (data not shown). Critically, at 3 dpi, mice infected
with the shFGF2-1-mice displayed anxiety-like (EPM) and social
avoidance behaviors (SI) as compared with scramble (Figure 8F),
indicating that FGF2 loss restricted to NG2 glia in the PFC suf-
fices to induce depressive-like behaviors in adult mice.
Our working model (Figure S8) proposes that the NG2 glia
play key roles in maintaining CNS homeostasis by mediating
astrocytic glutamate uptake and neuronal glutamatergic
signaling, at least partially through secreted factors, one of
which is FGF2. We conclude that chronic stress triggers loss
of NG2 glia, which results in the loss of homeostatic secretion
of critical NG2-glia-derived signaling cues, such as FGF2,
which in turn creates the CNS cellular and molecular dysfunc-
tion previously shown to underlie MDD and other stress
disorders.
DISCUSSION
In this study, we have defined a stringent functional link between
NG2 glia and depressive-like behaviors, identifying FGF2 pro-
duced by the NG2 glia as a putative modulator of the NG2 glia-
mediated CNS homeostasis. We employed a mouse model of
chronic social stress to show that NG2 glia loss is a hallmark ofNeuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc. 951
Figure 8. The Loss of NG2 Glia-Secreted FGF2 Participates in the Emergence of Depressive-like Behaviors
(A) Schematic representation of NG2 glia isolation protocol by FAC-sorting to obtain total RNA and perform PCR array from control, RES, and SUS mice.
(B) Representative plots of FACS gates used to isolate NG2 glial cells (PDGFRa+ cells; PE+) for PCR pathway array analysis.
(C) Table showing the growth factors and neurotrophinswith the highest differential expression among the groups and fold-changes alongwith reported functions
in this context and relevant references. Double downward arrows, significant downregulation, >10-fold change; downward arrow, significant downregulation,
<10-fold change; upward arrow, significant upregulation, <10-fold change; sideways downward arrow, downregulation trend; sideways upward arrow, upre-
gulation trend; horizontal arrows, no change (n = 5 per group; see Supplemental Information for references and statistical analysis).
(D) Lentiviral shRNA strategy to knock down mouse FGF2 in NG2 glial cells in the PFC of adult mice. Representative confocal images showing infected cells
(GFP+ cells) in the PFC at 3 days postinfection (3 dpi).
(E) At 3 dpi in the PFC of NG2CREnegmice (top panel, arrows), PDGFRa+ cells infectedwith shFGF2-1wereGFP+, while in the PFC of NG2CREposmice PDGFRa+
were GFPneg (bottom panel, arrows).
(F) Representative behavioral measures assessed at 3 dpi of mice injected with scramble shRNA or shFGF2-1. Plots shows percentage of time spent in the open
arms over total time assessed by EPM (n = 22/group) and average SI score assessed by SI (n = 11/group). dpi, days postinjection. Error bars, mean ± SEM (*p <
0.05; t test). Scale bars, 40 mm.
See also Figures S6 and S7.stress-susceptible mice and propose that, through decreased
FGF2 secretion, this loss creates region-specific deficits in
neuronal and astrocytic glutamatergic signaling ultimately lead-
ing to MDD-like behavioral deficits.952 Neuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc.NG2CRE/iDTR as a Suitable Model to Study NG2 Glia
Ablation
In the developing forebrain, NG2 glia arise from the ventral
germinal zones of the medial and lateral ganglionic eminences
(Hill and Nishiyama, 2014). Lineage tracing studies which have
temporally followed these early NG2 glia (Zhu et al., 2008a;
Zhu et al., 2008b) found, in addition to the expected myelinating
oligodendrocytes, forebrain and spinal cord astrocytes to be
among their progeny. We generated the iDTR-YFP line to char-
acterize CRE-expressing cells in the adult PFC. Our analysis
showed that 94% of the YFP+ cells were NG2 glia and 5%
were oligodendrocytes, with no apparent YFP expression in as-
trocytes. Since NG2 glia represent5% of all glial cells (Dawson
et al., 2003), the YFP+ oligodendrocytes could represent at most
1/20th of that amount, or 0.25% of the total number of glial cells.
Since oligodendrocytes represent >50% of the glial cells, at
most, 0.5%, or 1 out of every 200 oligodendrocytes, has a re-
combined iDTR/YFP cassette, which could even represent oligo-
dendrocytes generated in adulthood from mature NG2 glia,
as opposed to ones arising from developmental recombina-
tion events. Regardless, the very low frequency of YFP+ oligo-
dendrocytes and the lack of demyelination after NG2 glia
ablation in the PFC eliminates the concern that this model results
in significant oligodendrocyte ablation in addition to NG2 glia
ablation upon injection of DT. The additional evidence for the
absence of off-target effects on astrocytes were shown by the
lack of DT-driven cell death of primary astrocytes harvested
from the iDTR mice. Of note, this is in line with the observations
that a major source of astrocytes in the postnatal cortex in mice
arises from the local protoplasmic astrocytes (Ge et al., 2012).
NG2 expression has been observed also in pericytes of the
adult CNS (Ozerdem et al., 2001), which can render them sus-
ceptible to DT via CRE expression. Yet, we saw no alterations
either in NG2+ pericytes or associated vasculature following
NG2 glial cell ablation. A possible explanation for the lack of
DTR activation in off-target cell types might ensue from the ki-
netics of CRE recombination, which requires a significant level
and duration of CRE expression; below this threshold, very little
recombination occurs (Mao et al., 2001) (reviewed in Richardson
et al., 2011). Therefore, adult NG2 glia, which express high levels
of NG2, as opposed to the low levels of expression seen during
development, appear to be the only cells that undergo CRE-
mediated excision and are thus susceptible to ablation via injec-
tion of DT.
We also excluded the minor microglial activation observed
following NG2 glia ablation as a confounding factor, as it did
not lead to an inflammatory response. Similar large-scale cell
ablation studies have reported that microglia are largely un-
changed in their phenotype after Ara-C-induced ablation of
NG2 glia in the hypothalamus and DT-induced ablation of
DCX+ immature neurons in the hippocampus (Robins et al.,
2013; Vukovic et al., 2013). This is consistent with the findings
that the pharmacological ablation of microglia is also insufficient
either to prompt an inflammatory response by the surviving mi-
croglia progenitor population or to adversely affect brain vascu-
lature (Elmore et al., 2014; Parkhurst et al., 2013).
NG2 Glia Dynamics in Stress and Stress-Related
Disorders
Our data suggest that NG2 glia are a key cellular determinant of
symptom emergence in stress-related disorders. Under chronic
social stress, NG2 glial dynamics in the PFC went from tran-siently increased cell numbers during the early stages of stress
to a robustly reduced cell density in areas that play a critical
role in depression. This phenomenon was not a general
response to stress, since the NG2 glial density changed neither
in the PFC of resilient animals nor in areas involved in the patho-
physiology of MDD, i.e., the somatosensory cortex and striatum
of susceptible animals. NG2 glia have repeatedly been demon-
strated to be the first cell type to respond to any type of insult
to the adult CNS (Hampton et al., 2004; Hughes et al., 2013;
Kang et al., 2010), and our data here show that stress is no
exception: NG2 glia were rapidly perturbed in our rodent model
of depression. The rapid influence of stress upon NG2 glia also
stands in contrast to astrocytic perturbations observed in similar
animal models of chronic stress-induced depression, in which a
reduction in astrocyte density was observed only after a 35 day
stress protocol (Banasr et al., 2010).
The maintenance of NG2 glial density in the PFC via control
of proliferation rates is under tight autoregulation (Birey and
Aguirre, 2015; Hughes et al., 2013), although the physiological
reason for this has remained unclear. This dependence on
replacement renders NG2 glia a unique cellular target for
stress signals, putting the CNS functions they homeostatically
support at risk when proliferation is suppressed, as we show
here. Although identification of the upstream mechanisms
that decrease the proliferation rates of NG2 glia is yet to be
determined, a number of candidate pathways hold promise.
It has been recently shown that lithium, a mood stabilizer, en-
hances the proliferation of NG2 glia by stimulating the phos-
phorylation of GSK3b (Carter et al., 2012), a pathway heavily
implicated in MDD. In this context, 4 weeks of lithium treat-
ment was shown to increase GSK3b serine-9 phosphorylation
(Jope and Roh, 2006). The reduced number of pGSK3b+
PDGFRa+ cells suggests that downregulation of GSK3b phos-
phorylation in a subset of NG2 glia might underlie their
reduced proliferation after chronic stress. Another mechanism
that could account for NG2 glia loss is cell death, through
increased levels of glucocorticoids due to over-activation of
the HPA axis. Recently, it has been established that NG2
glia express glucocorticoid receptors (GRs) (Matsusue et al.,
2014) and that chronic glucocorticoid administration in rats
reduces their proliferation (Alonso, 2000). The hippocampus
and PFC have high GR expression, consistent with
the primary sites of NG2 glia loss in the susceptible mice after
SDSP.
NG2 Glia-Secreted Factors Mediate Astrocytic and
Neuronal Functions Lost after Ablation and Implicated
in MDD
The emergence of depressive-like behaviors following NG2 glia
ablation identifies a homeostatic loss-of-function in the adult
CNS for them. In line with this idea, we sought to identify the sys-
tems affected by the lost NG2 glia modulatory functions that
ultimately contribute to maladaptive behaviors. Our data suggest
a direct role for NG2 glia in regulating essential glutamate-
modulated systems, including astrocytic glutamate clearance
and neuronal excitatory glutamatergic signaling. Whether defi-
ciencies in optimal glutamate clearance directly cause the
observed glutamatergic neurotransmission deficits awaits futureNeuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc. 953
studies. Nonetheless, the data above imply that NG2 glia partici-
pates in the regulation of optimized glutamate signaling and gluta-
mate clearance. Given the nature of their immediate response to
chronic stress, the loss of NG2 glia might be one of the first reg-
ulatory element to affect glutamate system in this setting.
The Loss of NG2 Glia-Secreted FGF2 Suffices to Drive
Depressive-like Behaviors
We identified the growth factor FGF2 as a plausible factor
through which NG2 glia mediate CNS homeostasis and through
which their deficiency leads to anxiety-like behavior. Recent
evidence points to FGF2 as a key factor in the pathophysiology
of mood disorders, as it is one of the more intensively character-
ized growth factors in this context: FGF2 has been found at low
levels in MDD and can rescue depressive-like behaviors in
chronic stress models (Elsayed et al., 2012; Perez et al., 2009).
Our PCR array data showed low levels of FGF2 mRNA levels
in NG2 glia from susceptible animals, suggesting that a deficit
of production of this factor might predispose to the development
of depressive-like behavior by defective modulation of astro-
cytic and neuronal functions. Indeed, it has previously been
shown that FGF2 stimulation can increase GLAST levels, gluta-
mate uptake and phosphorylation of GluR (Figure 8C, see in-
figure references). Strikingly, NG2 glia-specific knockdown of
FGF2 in the PFC was sufficient to induce depressive-like
behavior in mice, demonstrating that even a functional perturba-
tion in a small population of NG2 glia is able to robustly influence
properties of astrocyte and neurons systematically, leading to
aberrations at the behavioral level. Although it is most likely
that FGF2 works in concert with other factors to mediate the
functions listed above, the loss of NG2 glia-derived FGF2 re-
mains as a factor that plays a crucial role in the emergence of
depressive phenotypes in the NG2 glia ablation and social
defeat models.
Our findings reveal that NG2 glia play essential roles in main-
taining normal adult brain function and that dysfunction of these
roles and the ultimate loss of NG2 glia are implicated in the path-
ophysiology of MDD and related disorders. Further advancing
our understanding of the cellular andmolecular targets regulated
by NG2 glia in stress disorders will provide novel therapeutic tar-
gets for antidepressant drug development.
EXPERIMENTAL PROCEDURES
Animals
Transgenic mouse lines were backcrossed to generate iDTR line. In the iDTR
mouse line, the gene encoding DTR (simian Hbegf, heparin-binding epidermal
growth factor-like growth factor) is under the control of the constitutive
Rosa26 locus promoter, and its expression is blocked by an upstream loxP-
flanked STOP sequence (see Elmore et al., 2014). The DTR is expressed after
Cre recombinase removes the STOP cassette, rendering only NG2-expressing
cells susceptible toDT.Wild-type littermates that are injectedwithDTwereused
as control animals for the experiments with systemic DT administration. No
adverse side effects of DT were observed when administered to the controls.
Diphtheria Toxin Administration
Mice were analyzed at 2, 3, and 7 days after the first injection (acute depletion
phase) and 2 days and 1, 2, and 3 weeks after 7DT administration (Figure 2A).
These time points were chosen to include the onset of NG2 glia death and
acute depletion (3–7 days) and recovery (3 weeks). For local DT infusions954 Neuron 88, 941–956, December 2, 2015 ª2015 Elsevier Inc.into the PFC, the following coordinates were used for cannula (Azlet) implan-
tation: anterioposterior, +1.5 mm; mediolateral from bregma, 0.5 mm; and
dorsoventral from dura, 1.4 mm.
Social Defeat Stress Paradigm
CD1 mice at 4–5 months of age were selected for aggressive behavior based
on a 3 day screening period for aggression behavior prior to SDSP (see Golden
et al., 2011 for full protocol procedures). Following 10 min of physical interac-
tion, the victim C57BL/6J mice were removed and placed on the opposite side
of the aggressor’s home cage behind a protective partition for the remainder
of the 24 hr period. The victims are introduced a novel set of aggressors
each day.
Electrophysiology
Glutamatergic synaptic transmission was investigated in the acute and recov-
ery periods after DT administration (Maffei et al., 2004). For the acute period,
recordings were performed at 7DT and 21dpDT in age-matched (P40) control
and ablated animals. Coronal slices containing PFC, primary PFC, somatosen-
sory cortex (S1), and striatum were prepared as previously described. Visual-
ized patch clamp recordings were obtained from layer 2/3 pyramidal neurons
in S1. AMPA mEPSCs were pharmacologically isolated and recorded in
voltage clamps (at 70 mV). Neurons with series resistances below 15 MU
and exhibiting less than 10% change throughout the recording were used
for analysis. Cumulative and ranked distributions of mEPSC amplitudes
were obtained from 50 events for each neuron.
pSico EGFP Lentiviral Flox/Flox Knockdown of Mouse shFGF2 in
NG2 Glial Cells of the Adult PFC
NG2 glial cells were targeted for knockdown of mouse FGF2 using a CRE/Lox
pSico lentiviral system(Ventura et al., 2004). Lentiviral (LV) stocks were pro-
duced and purified according to a previously published protocol (Taylor
et al., 2006). The final titer was 125 mg/ml p24 and 1.6 3 109 infectious
units (IU)/ml for the LV scramble control lentivirus, and 980 mg/ml p24 and
8 3 108 IU/ml for the LV shFGF2-1 construct. The vector stocks were diluted
in Hank’s balanced salt solution (HBSS) (Invitrogen, Carlsbad, CA). Primary
cortical mouse cultures as above were prepared to test mouse shFGF2
knockdown in NG2 glial cells. In order to determine the efficiency of lentiviral
particles targeting NG2 glial cells, cultures were transduced in vitro with LV
scramble or LV shFGF2-1 to -4, using 250,000 IU in 200 ml DMEM/F12 media.
Cultures were processed for FAC sorting and immunocytochemistry at several
days after infection (as indicated in Figure S7). For FAC sorting of PDGFRa+
cells after infection, cells were collected and incubated with isotype control
or cd140a-PE antibodies and then sorted populations were processed for
RT-PCR analysis and immunocytochemistry as above and previously descri-
bed(Aguirre et al., 2010). The shRNA sequence for mouse FGF2 were cloned
in the pSico vector (Addgene, catalog number 11578) and processed for LV
lentiviral production. The sequences used for shRNA for mouse FGF2 are as
follows: shFGF1-1 (GCCATACTGTTTCTTCCAATGTCTGCTAA); shFGF1-2
(CGTCAAACTACAACTCCAAGCAGAAGAGA); shFGF1-3 (GGCTCTACTGCA
AGAACGGCGGCTTCTTC); and shFGF1-4 (TTGAACGACTGGAATCTAATAA
CTACAAT).
For targeting NG2 glia in the PFC, adult NG2CRE+ and NG2CREneg mice
(P60–P90) were stereotaxically injected with scramble of LV shRNA GFP
construct. Briefly, adult mouse males were anesthetized as previously
described (Aguirre and Gallo, 2007) and placed in a stereotaxic frame.
Burr holes were drilled to permit bilateral stereotaxic injection of 2 ml of
LV shFGF2 or LV scramble (diluted in HBSS concentration mentioned
above) at a rate of 0.2 ml/min into the PFC (stereotaxic coordinates from
anterioposterior, +1.5 mm; mediolateral from bregma, 0.5 mm; and dorsoven-
tral-below the surface of the dura,1.4 mm). At 3 days after LV infection, mice
were processed for immunohistochemistry and behavioral analysis.
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